February 10, 2020 / 9:42 PM / 15 days ago

BRIEF-Revance Therapeutics Announces Proposed Private Offering Of $200 Mln Of Convertible Senior Notes Due 2027

Feb 10 (Reuters) - Revance Therapeutics Inc:

* REVANCE THERAPEUTICS INC - ANNOUNCES PROPOSED PRIVATE OFFERING OF $200 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027

* REVANCE THERAPEUTICS INC - INTENDS TO GRANT INITIAL PURCHASER OF NOTES AN OPTION TO PURCHASE UP TO AN ADDITIONAL $30 MILLION PRINCIPAL AMOUNT OF NOTES Source text: (bit.ly/2viNNjk) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below